Shaanxi Micot Pharmaceutical Technology Co., Ltd.

This study tested a drug called MT1013 for people on kidney dialysis who develop a bone-weakening condition called secondary hyperparathyroidism. Researchers gave 98 dialysis patients different doses of the drug or a placebo to check safety and see if it could lower a harmful hor…

This study tested whether an experimental injection called MT1013 could safely and effectively lower high parathyroid hormone levels in people with advanced kidney disease who are on regular dialysis. The trial involved 115 participants and compared MT1013 against both an existin…